Procedure guide · Reconstructive Plastic Surgery
Skin cancer reconstruction closes the defect left after a cancer is removed, most often on the face where sun exposure is greatest. The rule that governs everything is that clear margins are confirmed before anything is rebuilt, because reconstructing over residual tumour hides it. Options run from letting a wound heal on its own through grafts to local flaps, and surveillance continues afterwards for years.
Skin cancer reconstruction closes the defect left after a cancer has been removed, most often on the face because that is where sun exposure is greatest. The nose, the ear, the eyelid, the lip and the scalp account for the majority. It is among the commonest reconstructive procedures performed anywhere, and it is governed by one rule that outranks every aesthetic consideration.
That rule is that clear margins are confirmed before anything is rebuilt. Reconstructing over unconfirmed margins buries any remaining tumour beneath a flap, where it grows unseen and presents late, often larger and harder to treat. The reconstruction also destroys the anatomical landmarks that would be needed to find it. There are two safe ways to proceed: excise, dress the wound, wait for the pathology report and reconstruct a few days later, or use Mohs micrographic surgery, in which tissue is examined under the microscope during the procedure and further layers taken until margins are clear, allowing immediate reconstruction with certainty.
Mohs deserves explaining because patients frequently hear the name without understanding what it buys. It spares the maximum amount of normal tissue, which matters enormously on a nose or an eyelid where every millimetre counts, and it gives the highest cure rates for cancers with indistinct borders, recurrent cancers and those in high-risk sites. It takes longer, often a whole day with waiting between layers, and it is not needed for every skin cancer. Where it is available and indicated, it is the better approach.
The choice of reconstruction depends on more than the size of the hole. On the face, surgeons plan by aesthetic subunits so that scars fall on borders the eye already reads as edges. On concave surfaces such as the inner corner of the eye, the temple and parts of the ear, simply dressing the wound and letting it heal on its own frequently gives a better result than any repair, which surprises patients who assume more surgery means a better outcome. On convex surfaces it leaves a depressed pale scar, so this is decided by site rather than preference.
One consideration is specific to cancer and is worth knowing because it explains a choice that otherwise looks odd. Where recurrence risk is high, a surgeon may deliberately choose a skin graft over a better-matching flap, because a graft leaves the area thin and easy to examine while a flap covers the bed with moved tissue that hides what lies beneath. Choosing the less cosmetically appealing option for oncological reasons is good practice rather than lack of skill, and a surgeon who explains that reasoning is being thorough.
Function is prioritised over appearance on the face for reasons that are not aesthetic. An eyelid that cannot close fully exposes the cornea, causing damage and potentially threatening sight, so eyelid reconstruction is usually handled by an oculoplastic surgeon and function comes first. A lip that cannot seal causes drooling and impairs speech. A nostril rim pulled by tension obstructs breathing. Where these compete with symmetry, symmetry loses.
The reconstruction is not the end of treatment. Someone who has had one skin cancer on sun-exposed skin is at real risk of another, and the surrounding skin frequently shows the cumulative damage that produced the first. Surveillance continues for years, with regular skin checks, and sun protection becomes permanent rather than seasonal. That follow-up is the part that does not travel, and it is the main practical argument against arranging this abroad.
For anyone considering treatment in another country, the practical distinction is this. Excision and reconstruction as a single episode without margin control is unsafe wherever it happens. A planned reconstruction of a defect whose margins have already been confirmed clear is ordinary elective surgery and travels reasonably well, provided the histology report comes with you and skin surveillance continues at home.
Skin cancer reconstruction is one part of a treatment whose most important step is the excision, and confusing the two leads to poor decisions. The cure depends on removing the cancer completely; the reconstruction determines how the result looks. A beautifully executed flap over an incompletely excised tumour is a worse outcome than a plain skin graft over a clear margin, because recurrence under a flap is hidden and frequently presents late. This is why specialist units insist on confirmed margins before rebuilding, even when it means a second operation and a second anaesthetic.
Skin cancer reconstruction on the nose, the eyelids and the lips is disproportionately difficult relative to the size of the defect, because those structures have both a shape and a job. An eyelid has to close completely and sit against the eye, a lip has to seal and move, and a nostril has to stay open when breathing in. A repair that looks acceptable but leaves an eyelid turning outward or a nostril collapsing has failed functionally. These sites are the strongest argument for treatment by someone who reconstructs faces regularly.
Skin cancer reconstruction is increasingly performed in older patients, frequently in their 70s and 80s, and this shapes the plan. A staged forehead flap requiring 3 operations and 2 months with tissue attached across the face may be entirely reasonable for a 55-year-old and entirely wrong for someone of 85 on anticoagulants. Simpler options such as a graft, a local flap or in some cases allowing a small wound to heal by itself can give a good result with far less disruption. Age alone does not decide this, but general health, medication and what the patient wants all do.
Skin cancer reconstruction should be accompanied by a conversation about prevention, which is the part most likely to change the next 10 years. Daily broad-spectrum sun protection, hats, avoiding midday sun and regular self-examination measurably reduce the rate of new lesions in people who have already had one. Regular dermatological review catches the next cancer while it is small enough for a simple excision. For patients on immunosuppression after an organ transplant, who develop skin cancers far more frequently and more aggressively, that surveillance is essential rather than advisable.
Skin cancer reconstruction options follow the same ladder as elsewhere, but the rungs mean something different on a face. Allowing a small wound on a concave surface such as the inner corner of the eye or the bowl of the ear to heal by itself frequently gives an excellent result and is a legitimate choice rather than a failure to treat. Direct closure works where there is laxity. Local flaps borrow adjacent skin that matches. Grafts are used where nothing can be borrowed, and they are the option most likely to show as a patch.
Skin cancer reconstruction plans vary with the type of cancer. Basal cell carcinoma grows slowly and almost never spreads, so the question is purely local control. Squamous cell carcinoma can spread to lymph nodes, particularly on the ear and the lip, so the assessment extends beyond the lesion. Melanoma requires wider margins and frequently a sentinel node biopsy, and the reconstruction is planned around a defect whose size is set by the melanoma’s depth rather than by its visible edge.
Skin cancer reconstruction should not be scheduled before the pathology is understood, and this is the most common source of friction when treatment is arranged abroad. Margins reported after the fact, in a different laboratory and a different language, are difficult to act on once the patient has flown home. Where a flap has already been raised over them, a recurrence becomes both harder to detect and harder to treat.
Skin cancer reconstruction follow-up is as important as the operation and is usually the reason to keep treatment local. Recurrence is detected by someone examining the area regularly and knowing what it looked like at the start. Surveillance intervals of 3 to 6 months for the first 2 years are typical for higher-risk lesions, and that schedule assumes a clinician the patient can actually see.
Surgeons look for these points at the consultation.
Skin cancer reconstruction suits anyone with a defect after excision of a skin cancer whose margins have been confirmed clear, who is well enough for the closure proposed, and who understands that the plan depends on the site, the size, the type of cancer and the risk of it coming back.
Reasons a good surgeon will ask you to wait or choose something else.
Skin cancer reconstruction is deferred where margins are not yet confirmed clear, in active infection, in current smokers for flap reconstruction, where a high recurrence risk makes a flap unwise and a graft or open healing preferable, and where the patient is unwell enough that a simpler closure is safer.
Ask your surgeon which technique they recommend for you and why.
The skin wound is dressed and left to heal on its own over weeks, which on concave surfaces such as the inner corner of the eye or the temple frequently gives an excellent result.
The edges are brought together directly, with the scar placed along a natural crease or the border between two facial subunits.
Skin taken from behind the ear, the neck or the collarbone is laid into the defect, a common choice on the nose and in patients where a flap is unsuitable.
Adjacent facial skin is moved into the defect on its own blood supply, with scars placed in creases and subunit borders.
Step by step, from arrival to discharge.
The cancer is removed, either with Mohs surgery confirming margins during the procedure or with excision followed by histology before reconstruction.
Size, depth, site and which aesthetic subunit is involved, together with whether cartilage or bone is exposed, decide what reconstruction is possible.
Open healing, primary closure, graft or local flap, weighed against appearance, function and how easily recurrence could be detected.
Usually local anaesthetic as a day case, with scars placed along creases and subunit borders and care taken to avoid tension on eyelid, nostril or lip.
Facial sutures out at 5 to 7 days, graft dressings left undisturbed for around a week, and sun protection from the point the wound has healed.
Regular skin checks continuing for years, since a first skin cancer raises the risk of another in the surrounding sun-damaged skin.
Frequencies follow published guidance; your personal risk depends on your health and the surgeon.
One rule governs this page and everything else follows from it: margins are confirmed clear before anything is reconstructed. Rebuilding over residual tumour buries it beneath a flap, where it grows unseen and presents late, often larger and harder to treat. The reconstruction also destroys the anatomical landmarks needed to find it again. A clinic offering to excise a skin cancer and reconstruct the defect in a single visit, without any mechanism for confirming margins, is offering something that is convenient and unsafe.
There are two ways to satisfy the rule. The first is to excise, dress the wound, wait for the pathology report, and reconstruct a few days later once the margins are known. The second is Mohs micrographic surgery, in which the tissue is examined under the microscope during the procedure and further layers taken until margins are clear, so reconstruction can follow immediately with certainty. Mohs is particularly valuable on the face, where sparing normal tissue matters, and on cancers with a high recurrence risk or indistinct borders.
Which reconstruction is chosen depends on more than the size of the hole. On the face, surgeons plan by aesthetic subunits, so scars fall on the borders the eye already reads as edges. On concave surfaces such as the inner corner of the eye or the temple, simply letting the wound heal on its own frequently gives a better result than any repair, which surprises patients who assume more surgery means a better outcome. And where recurrence risk is high, a graft may be chosen over a flap deliberately, because a graft leaves the area easy to examine while a flap hides what lies beneath it.
Finally, the reconstruction is not the end of the treatment. Someone who has had one skin cancer on sun-exposed skin is at real risk of another, and the surrounding skin frequently shows the damage that produced the first. Surveillance continues for years, sun protection becomes permanent rather than seasonal, and that follow-up is the part that does not travel. It is the main practical argument against arranging this abroad.
Skin cancer reconstruction trades a defect for scars on the face. Good planning hides them in creases and subunit borders; they remain permanent.
Tension pulling on a lower eyelid, a nostril rim or the corner of the mouth, which can affect eyelid closure, breathing or oral competence rather than only appearance.
A skin graft healing paler, flatter and thinner than surrounding facial skin, giving a patched appearance that persists permanently.
Someone who has had one skin cancer is at raised risk of another, particularly on sun-damaged skin nearby, which is why surveillance continues for years.
Reduced sensation around the repair, usually improving over months and occasionally permanent in a small area.
Where margins were not confirmed first, remaining cancer is buried beneath the repair, grows unseen and presents late. This is the defining risk of skin cancer reconstruction.
Partial or complete loss of the repair, more likely in smokers, in irradiated skin and over exposed cartilage or bone.
Recovery from skin cancer reconstruction is usually straightforward and short. Most repairs are done under local anaesthetic as a day case, discomfort is mild, and the main inconvenience is a dressing on the face for a week. Facial sutures come out at 5 to 7 days, earlier than elsewhere on the body, because facial skin heals quickly and sutures left longer leave marks.
Where the wound is being left to heal on its own, the recovery looks different and takes longer. An open wound is dressed regularly for several weeks while it fills in and contracts, which requires patience and looks alarming in the middle of the process. On the right site it produces a better result than a graft would, and patients who understood that before starting cope with the weeks of dressings far better.
Grafts have one specific rule: the dressing is left undisturbed for around a week. A graft survives by absorbing nourishment from the bed beneath it and then growing new blood vessels into it, and disturbing it early is the commonest reason grafts fail. Where a bolster dressing has been stitched over a graft, it stays until the surgeon removes it.
Sun protection becomes permanent rather than temporary. A healing scar darkens readily with ultraviolet exposure and that darkening can be lasting, and more importantly the skin that produced one cancer is at risk of producing another. Daily sun protection and continuing skin checks are part of the treatment from this point onward rather than general advice.
Days 1-7
A dressing over the repair, kept dry. Swelling and bruising on the face, more around the eyes. Where the wound is healing openly, dressings are changed regularly.
Days 5-14
Facial skin sutures are removed at 5 to 7 days, elsewhere at 10 to 14. Flying is usually cleared at around day 5. Graft dressings are left undisturbed for around a week.
Weeks 3-8
Swelling resolves and the repair softens. Sun protection is essential from this point. Open wounds continue closing over several weeks.
Months 2-6
Redness fades and contour settles. Any revision or contour refinement is considered from around 6 months, not before.
Months 12 onward
Scars reach their settled appearance. Skin checks continue, since a first skin cancer raises the risk of another.
Well-planned facial repairs frequently become unremarkable at conversational distance within a year, particularly local flaps with scars placed on subunit borders.
Grafts remain paler, thinner and flatter than surrounding facial skin, giving a patched appearance that persists. That is the trade for a simpler operation and easier monitoring.
Open healing on concave surfaces such as the inner corner of the eye frequently produces an excellent result with no surgery at all, after several weeks of dressings.
The reconstruction does not end the treatment. Further skin cancers are common in the same sun-damaged skin, which is why surveillance continues and sun protection becomes permanent.
Skin cancer reconstruction is almost always funded, because it is cancer treatment rather than cosmetic surgery, and the funded pathway includes the excision, the reconstruction and the surveillance that follows. Since surveillance matters as much as the repair to long-term health, that integration is its main advantage.
Where it is paid for privately, the prices on this site come from verified clinic records for each named procedure. The variables are the size and site of the defect, whether Mohs surgery is used, and whether the closure is open healing, a graft or a flap.
The cost most often overlooked is what follows. Further skin cancers are likely in the same sun-damaged skin, so budgeting for a single reconstruction while ignoring years of surveillance and probable further excisions understates the picture considerably.
Why quotes for the same procedure differ, so you can compare packages fairly.
Options to weigh before deciding, surgical and non-surgical.
Dressing the wound and letting it close on its own, which on concave facial surfaces frequently gives a better result than any repair and keeps monitoring easy.
Simpler, quicker, and deliberately chosen where recurrence risk is high because it leaves the area thin and easy to examine.
For some superficial cancers, topical treatment, photodynamic therapy or radiotherapy can avoid a surgical defect entirely.
An option for some skin cancers in patients unsuited to surgery, though it damages surrounding tissue and complicates any later reconstruction.
Excising first, dressing the wound and reconstructing days later once margins are confirmed, which is the standard safe approach without Mohs.
Ask the same questions at every consultation so you can compare answers.
Because reconstructing over residual tumour buries it beneath the skin repair, where it grows unseen and presents late, often larger and harder to treat. The reconstruction also destroys the landmarks needed to find it.
Surgeons either wait for the pathology report and reconstruct a few days later, or use Mohs surgery to confirm margins during the procedure. A single visit with neither mechanism is convenient and unsafe.
A technique in which the cancer is removed in thin layers and each layer examined under the microscope immediately, with further layers taken until the margins are clear. Reconstruction then follows the same day with certainty.
It spares the maximum amount of normal tissue, which matters on the face, and gives the highest cure rates for cancers with indistinct borders or a high recurrence risk. It takes longer and is not needed for every skin cancer.
On some skin sites, yes, and this surprises people. Concave surfaces such as the inner corner of the eye, the temple and parts of the ear frequently heal beautifully on their own, sometimes better than any repair.
It means several weeks of dressings and an open wound, which requires patience. On convex surfaces such as the nose tip or the cheek it tends to leave a depressed, pale scar, so it is chosen by site rather than by preference.
A flap matches skin colour and thickness far better because the tissue comes from next door, and it works over cartilage and bone where a graft would fail. A graft is quicker, has a minor donor site and leaves the area easy to examine.
That last point matters where recurrence risk is high. A surgeon may deliberately choose a graft over a better-looking flap so that any recurrence is visible rather than hidden beneath moved tissue.
Skin cancer reconstruction can distort a structure if a repair is closed under tension near a mobile one. Pulling on a lower eyelid, a nostril rim or the corner of the mouth affects eyelid closure, breathing or oral competence rather than only appearance.
Avoiding that is why surgeons sometimes choose a more complex repair than the size of the defect suggests. Function is prioritised over the simplest closure.
Less than most people fear, where it is planned well. Facial scars placed along natural creases or on the borders between aesthetic subunits are frequently unremarkable at conversational distance by a year.
A graft is the exception, since it commonly remains paler and flatter than surrounding skin, giving a patched appearance. Ask which is planned and see the surgeon’s own results at a year.
Most skin cancers treated with clear margins do not recur at that site. What is more likely is a new skin cancer elsewhere, because the skin that produced the first has the same sun damage across it.
That is why surveillance continues for years and why sun protection becomes permanent. Someone who has had one skin cancer should have their skin checked regularly rather than only when something appears.
Usually not. Most skin cancer excisions and reconstructions are done under local anaesthetic as a day case, sometimes with sedation for longer or more anxious cases.
General anaesthesia is used for large defects, for free tissue transfer, for children and occasionally where the site is difficult. Ask which is planned, since it affects the setting and the cost.
Eyelid skin reconstruction is specialised because the eyelid must close fully to protect the eye. A repair that looks acceptable but leaves the eye exposed causes corneal damage and can threaten sight.
These are usually managed by an oculoplastic surgeon rather than a general plastic surgeon. Function comes first and appearance second, which occasionally produces a result that looks like a compromise.
Almost always, since skin cancer reconstruction is treatment rather than cosmetic surgery. Excision, reconstruction and follow-up are usually delivered together within the same service.
That integration is its main advantage over arranging it privately. Surveillance after treatment matters as much as the reconstruction and is included in a funded pathway.
Skin cancer reconstruction is a poor fit for travel. Margins must be confirmed, which frequently means waiting days between excision and reconstruction, and surveillance for further cancers continues for years where you live.
If a lesion has already been excised with confirmed clear margins and you are having a planned reconstruction of the resulting defect, that travels better. Bring the histology report.
Someone working within a skin cancer service with access to margin control, who plans by facial subunits and can explain why they are choosing a graft, a flap or open healing in your case.
Ask how margins will be confirmed before reconstruction, who provides skin surveillance afterwards, and to see their own patients at a year rather than at 6 weeks.
A technique in which the skin cancer is removed in thin layers and each layer is examined under the microscope immediately, so further tissue is taken only where cancer remains.
It gives the highest cure rates while removing the least normal tissue, which is why it is preferred on the face. It takes most of a day because of the waiting between layers, and reconstruction follows once margins are clear.
Because basal and squamous cell cancers extend microscopically beyond what is visible, particularly around nerves and in recurrent lesions. A margin of normal-looking skin has to go with the tumour.
Patients are frequently surprised by the size of the wound after a small-looking spot is removed. Being warned of this beforehand is part of a proper consent conversation.
Where skin margins are confirmed during the operation, as in Mohs surgery or with frozen sections, yes. Where the specimen is sent away and takes days to report, the wound is dressed and reconstruction follows.
The delay is deliberate rather than a scheduling failure. Closing a flap over tissue that later proves to contain cancer buries recurrence where it cannot be seen.
Most likely. Someone who has had one non-melanoma skin cancer has a substantially raised chance of another within 5 years, because the same sun exposure affected the whole area.
This is why continuing skin surveillance matters more than the reconstruction itself, and why treatment is better anchored to a dermatologist you can see regularly than to a single visit.
NHS2024Regulator
National Institute for Health and Care Excellence2022Clinical guideline
American Society of Plastic Surgeons2024Professional society
Consultation request
Tell us the procedure and destination you are considering. We forward your request to the verified clinic you select.